A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of ...

LipiPB Red shows longer fluorescence lifetimes in stable lipid droplets (red) and shorter lifetimes as they undergo degradation (blue). This probe revealed that lipid droplets sequentially degrade, ...

MILAN — A single dose of a monoclonal antibody against an inhibitor of an enzyme involved in triglyceride degradation appears to substantially lower triglyceride and cholesterol levels, suggests a ...

ATLANTA, GA—Investigational agents that work by inhibiting apolipoprotein C-III (APOC3) are effective at reducing triglyceride levels, two phase IIb studies show. In Bridge-TIMI 73a, treatment with ...

Lysosomal acid lipase deficiency is a rare genetic condition that causes fat to build up in your body’s cells, especially in your liver and spleen. Lysosomal acid lipase deficiency (LALD) is a rare ...